Therapeuticsmd, Inc. (TXMD) Technical Analysis
$1.40▲1.25%
Market is closed - opens 7 PM, 09 May 2025
Insights
- Therapeuticsmd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Therapeuticsmd stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Therapeuticsmd stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Therapeuticsmd stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 72.91 | Sell |
Stochastic | 75.44, 75.86 | Neutral |
Ultimate Oscillator | 50.03 | Neutral |
Stochastic Relative Strength Index | 81.79, 89.22 | Sell |
Moving Average Convergence Divergence | 0.12, 0.1 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.33 | Buy |
20 | 1.18 | Buy |
50 | 1.0 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.32 | Buy |
20 | 1.22 | Buy |
50 | 1.1 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.34 | Neutral |
20 | 1.24 | Buy |
50 | 1.0 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.44 | Buy |
20 | 1.38 | Buy |
50 | 1.17 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.44 | Sell |
20 | 1.45 | Buy |
50 | 1.29 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 1.49 |
Resistance L2 | 1.47 |
Resistance L1 | 1.43 |
Pivot Point | 1.41 |
Support L1 | 1.36 |
Support L2 | 1.34 |
Support L3 | 1.29 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.